Discover
ESLA
Estrella Immunopharma, Inc.
0.98
1 x 1.14
1 x 1.17
bid
ask
-
0.06
5.53%
1 @ 04:00 PM
1.02 +0.04 (3.82%)
| Ytd | -37.02% | |
| 1y | 14.11% |
0.96
day range
0.99
0.78
52 week range
3.15
| Open | 0.98 | Prev Close | 1.04 | Low | 0.96 | High | 0.99 | Mkt Cap | 42.28M |
| Vol | 164.98K | Avg Vol | 82.01K | EPS | -0.34 | P/E | N/A | Forward P/E | N/A |
| Beta | 0.24 | Short Ratio | 0.07 | Inst. Own | 0.55% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 1.21 | 200-d Avg | 1.44 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 2.29M | ||
| Research and Development Expense | 1.40M | ||
| Selling, General and Administrative Expense | 891.79K | ||
| Operating Income | -2.29M | ||
| Net Income | -2.29M | ||
| Net Income Common Stock | -2.29M | ||
| Net Income Common Stock (USD) | -2.29M | ||
| Consolidated Income | -2.29M | ||
| Earnings per Basic Share | -0.05 | ||
| Earnings per Basic Share (USD) | -0.05 | ||
| Earnings per Diluted Share | -0.05 | ||
| Earning Before Interest & Taxes (EBIT) | -2.29M | ||
| Earning Before Interest & Taxes (USD) | -2.29M | ||
| Weighted Average Shares | 42.12M | ||
| Weighted Average Shares Diluted | 42.12M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.93M | ||
| Cash and Equivalents (USD) | 1.93M | ||
| Current Assets | 2.16M | ||
| Total Assets | 3.66M | ||
| Current Liabilities | 8.93M | ||
| Total Liabilities | 8.93M | ||
| Accumulated Retained Earnings (Deficit) | -39.28M | ||
| Shareholders Equity | -5.27M | ||
| Shareholders Equity (USD) | -5.27M | ||
| Assets Non-Current | 1.50M | ||
| Trade and Non-Trade Payables | 14.95K | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 7.24M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 543.10K | ||
| Issuance (Purchase) of Equity Shares | 8.00M | ||
| Net Cash Flow from Operations | -6.70M | ||
| Share Based Compensation | 146.71K | ||